В этом же номере журнала статья O'Brien et al. "Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial", с конфликтующими со статьей da Fonseca et al. результатами:
Conclusion. Prophylactic treatment with vaginal progesterone
did not reduce the frequency of recurrent
preterm birth (≤32 weeks) in women with a history
of spontaneous preterm birth. The effect of progesterone administration in patients at high risk for preterm delivery
as determined by methods other than history alone (e.g.
sonographic cervical length) requires further investigation.
Следом идет статья DeFranco et al. "Vaginal progesterone is associated with a decrease in risk for
early preterm birth and improved neonatal outcome in
women with a short cervix: a secondary analysis from a
randomized, double-blind, placebo-controlled trial"
Conclusion. Vaginal progesterone may reduce the rate
of early preterm birth and improve neonatal outcome
in women with a short sonographic cervical length.
Причем в обоих статьях приведены результаты мультицентровых исследований, проведенных в США.
|